Corrigendum: Designer Leptin Receptor Antagonist Allo-Aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models

Frontiers in Molecular Biosciences - Switzerland
doi 10.3389/fmolb.2016.00075
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Effects of High Affinity Leptin Antagonist on Prolactin Receptor Deficient Male Mouse

PLoS ONE
Multidisciplinary
2014English

A Novel Glucagon Receptor Antagonist Inhibits Glucagon-Mediated Biological Effects

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

Involvement of Agouti-Related Protein, an Endogenous Antagonist of Hypothalamic Melanocortin Receptor, in Leptin Action

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
1999English

Effects of YM905, a Novel Muscarinic M3-Receptor Antagonist, on Experimental Models of Bowel Dysfunction in Vivo

The Japanese Journal of Pharmacology
2001English

Leptin Secretion and Leptin Receptor in Human Stomach

Gastroenterology
HepatologyGastroenterology
2000English

Topical Interleukin-1 Receptor Antagonist Inhibits Inflammatory Cell Infiltration Into the Cornea

Experimental Eye Research
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2008English

Designer Fermion Models in Functionalized Graphene Bilayers

Physical Review Research
2019English

Leptin Receptor Signaling: Pathways to Leptin Resistance

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2011English

Human Leptin Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy